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Abstract 
Background: Gastric carcinoma (GC) is a rather rare pathological finding in dogs, with the exception of some breeds 
which seem predisposed. The etiopathogenesis is largely unknown in dogs, whereas in humans GC often develops 
from gastric mucosal metaplasia and dysplasia. This study investigates whether dogs of certain breeds are more often 
subject to gastroduodenoscopy (GDS), and diagnosed with GC, mucosal metaplasia or dysplasia. A retrospective clini-
cal database search was performed at the Veterinary Teaching Hospital at the University of Helsinki, Finland. The fol-
lowing inclusion criteria were applied to estimate relative risk for metaplasia/dysplasia and GC: dogs from pure breeds 
with at least five individuals subject to GDS with histopathology of gastric biopsies.
Results: Between 2006 and 2016, from a total of 54945 canine patients presented, 423 dogs underwent GDS. 
Inclusion criteria were met in 180 dogs of 20 different pure breeds. Eight dogs had GCs (mean age = 9.8 ± 1.7 years): 
Belgian Tervuren (n = 4), Collie (n = 2), Golden Retriever (n = 1) and Jack Russel Terrier (n = 1). Fourteen dogs of eight 
breeds had gastric mucosal metaplasia or dysplasia. A log-binomial statistical model revealed that dogs in the fol-
lowing breeds had a significantly higher probability to undergo GDS than the others in the study population: Aus-
tralian Terrier, Belgian Tervuren, Cairn Terrier, Collie and Siberian Husky. Belgian Tervuren was found at higher risk to 
be diagnosed with GC [RR = 19 (5.7–63.9; P < 0.0001)], as well as mucosal metaplasia/dysplasia [RR (7.6; 2.95–19.58; 
P < 0.0001)], as compared to the other breeds included. Shetland Sheepdog had an increased RR (5.83; 1.75–19.45; 
P = 0.0041) for metaplasia.
Conclusions: The results indicate a very low incidence of GC in dogs. The Belgian Tervuren, however, appears as pre-
disposed. The histopathologic descriptions of mucosal changes such as metaplasia and dysplasia were also rare, but 
were more frequent in the Belgian Tervuren. Previous reports of these changes in dogs are very scarce, but they might 
be presumably related to GC in dogs, as they are in humans. Future research should investigate the possible role of 
metaplasia and dysplasia in the development of GC in dogs, especially those of predisposed breeds.
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Background
Gastric carcinoma (GC) is a rare pathologic finding in 
dogs, as it corresponds to less than one percent of all 
neoplastic changes identified in dogs [1, 2]. The most 
common type of gastric neoplasm in dogs is adenocar-
cinoma, which is diagnosed at around 10  years of age, 
with initial clinical signs similar to those of other chronic 
gastrointestinal disorders [2–5]. Most gastrointestinal 
carcinomas in humans are known to evolve from super-
ficial, flat changes classified as metaplastic or dysplastic 
according to their degree of cellular differentiation [6, 7]. 
GC is the fifth most common type of cancer in people 
worldwide, and endoscopic biopsy is essential for diag-
nostic and staging [8]. Visual enhancement techniques 
such as chromoendoscopy and narrow band imaging 
are often applied for cancer screening and surveillance, 
as they can help improve the diagnostic yield of discrete 
mucosal changes [9]. The pathogenesis in humans is 
complex and not fully understood, but in approximately 
90% of the cases it involves a multistep, multifactorial 
process. The progression from normal mucosa to chronic 
gastritis, further evolving to atrophic gastritis, intestinal 
metaplasia, dysplasia and adenocarcinoma, occurs over 
several years [10]. However, challenging this classic his-
togenetic pathway in which metaplasia and dysplasia are 
well-recognized pre-neoplastic changes, human GC can 
also develop from otherwise normal gastric mucosa. Dif-
fuse gastric cancer, for example, is rare and often devel-
ops in a hereditary setting from foci of superficial signet 
ring carcinoma in  situ [11]. Gastric infection with Heli-
cobacter pylori plays a major role among environmental 
factors contributing to an increased risk of gastric cancer 
in humans [12], along with dietary factors including high 
intake of salt and preserved or smoked food (especially 
meat products), and low consumption of fresh fruit and 
vegetables [13].
The etiology of GC in dogs is still unknown, and it is 
suspected to be as complex as in humans [14]. The car-
dinal histological changes in canine gastric carcinogen-
esis remain undetermined, and the correlation between 
gastric polyps, Helicobacter spp. and GC has not yet 
been demonstrated [5, 15, 16]. A study on 14 Norwegian 
Lundehund dogs describes findings of mucous meta-
plasia in association with varying degrees of atrophic 
gastritis and intestinal lymphangiectasia. Additionally, 
four of those dogs had gastric neoplasia, which suggests 
that the changes represent a single pathological process 
[17]. In a further study with a total of eight Lundehunds 
with gastric neoplasia, it seems that such tumors are 
rather of neuroendocrine origin (derived from entero-
chromaffin-like-cells), possibly secondary to gastric 
atrophy and hypergastrinemia [18]. However, canine 
GC is not always associated with atrophic gastritis and 
comprehensive studies demonstrating the progression of 
atrophy towards metaplasia, dysplasia and gastric cancer 
in dogs are still lacking.
Previous retrospective studies based on data from 
canine cancer registry, records from specialists, pathol-
ogy laboratories and breeders have shown breed pre-
disposition to GC in the Belgian Tervuren, Bouvier des 
Flandres, Groenendael, Collie, Chow–Chow, Poodle, 
Norwegian Elkhound and a few other breeds, which 
implies a genetic background for the disease [1, 3, 4, 19, 
20]. In Finland, information about breed association to 
gastric cancer has been missing.
The present study was conducted to investigate which 
pure breeds are most commonly subject to gastroduo-
denoscopy (GDS) at the Veterinary Teaching Hospital of 
the University of Helsinki, a national referral center. The 
most important objective was to determine the probabil-
ity of dogs in different breeds undergoing endoscopy with 
mucosal biopsy for histology to be diagnosed with gastric 
carcinoma, metaplasia or dysplasia, as a possible evidence 
of breed predisposition also in Finland. The overall aim of 
this study was to gather information about gastric can-
cer and metaplastic or dysplastic changes as recognizable 
features in canine patients undergoing endoscopy with 
gastric mucosal biopsy for histology. This study relies 
on the hypothesis that, in the clinical setting of an endo-
scopic unit, certain breeds can be found affected with GC 
and mucosal metaplasia/dysplasia more commonly than 
others. The study therefore aims at investigating a possi-
ble association between individual breed, submission to 
GDS, and diagnosis of gastric carcinoma and metaplastic 
or dysplastic mucosal changes in histopathology.
Methods
The study was designed as a retrospective cohort on 
the diagnosis of GC, metaplasia and dysplasia in dogs 
subjected to GDS. The source population of this study 
comprises all dogs presented at the Veterinary Teach-
ing Hospital between January 2006 and December 2016. 
A computerized database search was performed on 
the records throughout this period. The study popula-
tion included dogs which belong to a pure breed having 
a minimum of five dogs subject to GDS with complete 
histopathological report based on gastric biopsies. The 
Belgian Tervuren is herein regarded as a breed on its 
own. The breed Collie includes both rough and smooth 
haircoat varieties (Border Collie and Shetland Shepherd 
being separate pure breeds).
The endoscopic biopsy samples were collected in a 
standardized fashion: at least eight gastric mucosal frag-
ments were taken onto wood chips and then immediately 
immersed (upside down) in 10% neutral buffered for-
malin. After 24  h fixation, the biopsies were processed, 
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paraffine-embedded, sectioned at 4 microns and stained 
with hematoxylin and eosin (HE). Special staining such as 
periodic acid-Schiff (PAS) or Warthin–Starry (WS) were 
applied when indicated.
The endoscopic mucosal biopsy samples were examined 
at the University of Helsinki by veterinary pathologists 
adhering to a standardized assessment protocol since 2006. 
The standard reporting template included the following 
parameters as main criteria for histopathological evalua-
tion of the stomach: number of biopsy samples examined, 
epithelial surface characterization, amount of intraepithe-
lial lymphocytes, presence of Helicobacter-like organisms, 
characterization and amount of mononuclear and granu-
locyte infiltration in lamina propria, presence of lymphoid 
follicles, characterization of fundic glands, and whether 
pepsinogen and HCl-producing cells are identified regu-
larly, or else substituted by mucous cells (metaplasia) [21]. 
Gland structure was also evaluated regarding presence of 
fibrosis, glandular nesting and structural changes which 
could be related to dysplasia. The World Small Animal 
Veterinary Association standards and guidelines were 
applied from 2008 onwards and the template was updated 
accordingly, regarding grading of inflammatory changes 
(0–3: normal, mild, moderate, severe) [22, 23]. The diagno-
ses were given under the supervision of, and in consensus 
with, a board-certified pathologist (PS).
The complete histopathological record of endoscopic 
biopsies from each patient of the study population was 
revisited for findings consistent with either gastric carci-
noma (GC), dysplasia or metaplasia, in addition to other 
features [21–23]. Histologic sections from the patients 
presenting these specific lesions were re-examined by a 
board-certified pathologist (PS) for verification of the 
diagnosis and consistency of the results.
Statistical methods
All of the outcomes tested were binary, because the pres-
ence or absence of GDS, GC or metaplasia/dysplasia was 
considered for each case studied. A log-binomial model 
was applied for each outcome variable, and the probabil-
ity of presence was modelled with 95% confidence inter-
vals (CI). The models were re-run separately for each 
breed in the analysis population comparing the breed of 
interest to other breeds. Relative probability to undergo 
GDS (numerically equivalent to relative risk) was calcu-
lated for each selected breed in comparison to all other 
canine patients visiting the hospital in the period (source 
population). The individual histopathological diagnosis 
from dogs of breeds meeting the inclusion criteria (study 
population) was considered for the calculation of rela-
tive risk (RR) to be diagnosed with gastric metaplasia/
dysplasia, or carcinoma, and computed for each breed in 
comparison to the other breeds included. P-values < 0.05 
were considered significant. All analyses were done using 
 SAS® System for Windows, version 9.3 (SAS Institute 
Inc., Cary, NC, USA).
Results
Pure breeds undergoing gastroduodenoscopy (GDS)
Between 2006 and 2016, the source population included 
a grand total of 54,945 canine patients being presented at 
the hospital. The study population was recruited out of 
423 dogs which underwent GDS for diagnostic reasons, 
30 of which being mixed-breed dogs. The inclusion crite-
ria mentioned above were met by 180 dogs representing 
20 different pure breeds. The study population consisted 
of 75 intact males, 26 castrated males, 46 intact females 
Table 1 Study population: breeds with  at  least 
five dogs undergoing gastroduodenoscopy (GDS) 
and  histopathological examination of  biopsy samples, 
selected for  inclusion from  the  source population of  all 
dogs presented between 01.01.2006 and 31.12.2016
Study population is indicated in bolditalic
Source population is indicated in italic
a Includes individual dogs from the selected breeds which were excluded from 
the study due to lack of histopathological diagnosis (foreign body retrieval, no 
biopsy taken or biopsy lost to follow-up)
b Total number of GDS patients in the period
Breed Total dogs 
presented
Dogs 
undergoing 
GDS
Australian Terrier 245 5
Belgian Tervuren 196 9
Border Collie 430 5
Cairn Terrier 522 11
Chihuahua 1729 5
Collie 673 27
Dachshund 1609 7
French bulldog 845 7
German Shepherd 2110 18
Golden Retriever 1216 15
Hovawart 328 5
Jack Russell Terrier 1149 7
Labrador retriever 2124 14
Miniature Schnauzer 1003 7
Parson Russell Terrier 496 6
Rottweiler 794 10
Shetland Sheepdog 734 5
Siberian Husky 219 5
Staffordshire Bull Terrier 592 6
West Highland White Terrier 690 6
Dogs in the breeds above 17,704 180
Other breeds/mixed (not included) 37,241 243a
All dogs in the period 54,945 423b
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and 33 sterilized females, which underwent GDS at the 
mean age of 5.3 ± 3.4 years (n = 180). These dogs corre-
spond to 43% of all GDS patients in the period (Table 1). 
Twelve other individual dogs of the breeds included had 
already been excluded from the study either because his-
topathological information was lost (n = 3) or no biopsies 
were taken during GDS (n = 9). Six of those nine dogs 
had gastric foreign bodies removed (plastic; wood; nee-
dles; stone) and one presented biliary tract changes and 
underwent endoscopic retrograde cholangiopancreatog-
raphy followed by surgical removal of the gallbladder.
When comparing the study population with the source 
population, a log-binomial model revealed significantly 
higher relative probability to undergo GDS in the follow-
ing breeds as compared to dogs of other breeds (RR; 95% 
CI lower–higher; P value): Australian Terrier (2.67; 1.12–
6.39; P = 0.0274), Belgian Tervuren (6.07; 3.18–11.58; 
P < 0.0001), Cairn Terrier (2.78; 1.54–5.03; P = 0.0007), 
Collie (5.5; 3.75–8.06; P < 0.0001) and Siberian Husky 
(2.99; 1.25–7.15; P = 0.0138). Chihuahuas underwent 
GDS significantly less often than dogs of other breeds 
(0.37; 0.15–0.89; P = 0.0261) (Fig. 1).
Gastric carcinoma
Eight of the dogs included in the study were diagnosed 
with gastric adenocarcinomas, which was the only 
type of gastric neoplasm seen in the study population. 
Affected dogs belonged to the following breeds: Belgian 
Tervuren (n = 4, including one signet-cell carcinoma), 
Collie (n = 2), Golden Retriever and Jack Russel Terrier 
(Table 2). Five of them were female and three were male. 
Concerning age at diagnosis of GC, the youngest patient 
was 7.8 years old when the examination was performed 
(mean age = 9.8 ± 1.7 years; see also Table 3). The Belgian 
Tervuren was found at much greater relative risk for 
being diagnosed with GC from histopathological exami-
nation of endoscopically obtained gastric biopsies (33.4; 
6.43–173.36; P < 0.0001) in comparison to other breeds 
(Fig. 2).
Metaplasia and dysplasia in gastric mucosa
Changes histologically described as metaplastic or dys-
plastic were seen in 14 dogs in the following breeds: Bel-
gian Tervuren (n = 4), Collie (n = 2), Golden Retriever 
(n = 2), Shetland Sheepdog (n = 2), Dachshund (n = 1), 
Hovawart (n = 1), Siberian Husky (n = 1) and Stafford-
shire Bull Terrier (n = 1). The mean age when these 
patients underwent GDS was 7.9 ± 2.6 years. Significant 
statistical differences were found for the diagnosis of 
either metaplasia or dysplasia in Belgian Tervuren com-
pared to other breeds: RR (7.6; 2.95–19.58; P < 0.0001). 
The Shetland Sheepdog was found at significantly 
increased RR (5.83; 1.75–19.45; P = 0.0041) for metapla-
sia (dysplasia was not seen in this breed) compared to 
dogs of other breeds (Fig. 3).
Endoscopic and histopathological diagnosis
The final diagnosis considered for all of the analyses was 
achieved by endoscopic examination and sampling, fol-
lowed by histopathological confirmation. All dogs pre-
senting the changes of concern were also found with 
concomitant inflammatory changes (Table  3). Each set 
of sample images shown in this article correspond to 
a single patient, respectively diagnosed as carcinoma 
(Figs. 4, 5), metaplasia (Fig. 6) or dysplasia (Fig. 7). Chro-
moendoscopy and narrow band imaging were applied in 
one Belgian Tervuren presented with chronic vomiting, 
whose brother from the same litter had been euthanized 
Fig. 1 Relative probability to undergo GDS for dogs of the selected 
breeds in comparison to all other dogs in the source population. *The 
difference is statistically significant (P < 0.05)
Table 2 Number of  dogs in  each breed undergoing 
gastroduodenoscopy (GDS), and  diagnosed with  gastric 
carcinoma (GC), dysplasia or  metaplasia from  endoscopic 
biopsy samples taken from 01.01.2006 to 31.12.2016
Breed GDS GC Dysplasia 
or metaplasia
Belgian Tervuren 9 4 4
Collie 27 2 2
Dachshund 7 – 1
Golden Retriever 15 1 2
Hovawart 5 – 1
Jack Russell Terrier 7 1 –
Shetland Sheepdog 5 – 2
Siberian Husky 5 – 1
Staffordshire Bull Terrier 6 – 1
Total in these breeds 86 8 14
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due to a massive GC. The most prominent endoscopic 
and respective histopathological changes found in this 
patient are in Fig. 7.
Discussion
Some dog breeds (namely Australian Terrier, Belgian Ter-
vuren, Cairn Terrier, Collie and Siberian Husky) under-
went GDS significantly more often as compared to the 
other breeds in this study. Chihuahua was scoped signifi-
cantly less often than others; this breed with a relatively 
small body size is rather common in the source popula-
tion. These findings remain largely unexplained, however 
breed distribution (Table 1) and relatively low overall fre-
quency of GDS (low sample sizes) may have influenced 
the results. It is not clear whether it was the severity of 
gastrointestinal signs alone, or any other issues that 
might have influenced the probability for certain breeds 
to undergo GDS. It would be reasonable to speculate that 
an expected breed predisposition to GC, as previously 
reported for the Belgian Tervuren [1, 3, 19], might poten-
tially bias the approach of clinicians and owners towards 
submitting patients of this breed to endoscopy earlier, or 
more often. The fact that dogs of certain breeds undergo 
GDS more often might as well indicate a higher preva-
lence of gastrointestinal disorders in general, which may 
warrant more extensive studies in such breeds.
The Belgian Tervurens that underwent GDS in this 
study were consistently found at much higher risk of 
being diagnosed with GC than dogs of any other breed. 
This finding is in accordance with previous studies that 
used pathological records and cancer registry data of 
Table 3 Breed, age (years), sex and  concomitant changes found in  each of  the  dogs diagnosed with  gastric carcinoma 
(GC)
LP lymphoplasmacytic, G gastritis, Fs sterilized female, Mc castrated male
Breed Age Sex Inflammatory change Structural change
Belgian Tervuren (n = 4) 7.8 F Moderate chronic LP G Glandular dysplasia
9.7 F Moderate chronic LP G –
9.2 M Moderate chronic LP G with neutrophilic com-
ponent and severe gland hyperplasia
Glandular dysplasia, 
epithelial dysplasia and 
atypia
11.0 M Severe chronic LP G –
Collie (n = 2) 8.6 F Moderate chronic LP G –
8.5 Fs Moderate chronic atrophic G Mucinous metaplasia
Golden Retriever 10.8 F Severe chronic LP G with neutrophilic compo-
nent and ulcerative mycotic G
–
Jack Russell Terrier 12.9 Mc Severe gland hyperplasia, mild LP G –
Fig. 2 Relative risk to be diagnosed with gastric carcinoma for 
selected breeds in comparison to the other breeds in the study 
population. *The difference is statistically significant (P < 0.0001)
Fig. 3 Relative risk to be diagnosed with gastric mucosal metaplasia 
or dysplasia for selected breeds in comparison to the other breeds 
in the study population. *The difference is statistically significant 
(P < 0.005)
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other countries such as Italy, Netherlands or Norway, in 
which the Belgian Tervuren were also considered to be 
highly predisposed to GC [1, 3, 19].
Gastric metaplasia or dysplasia were almost as rarely 
seen as GC, with significantly higher relative risks 
found for the Belgian Tervuren and Shetland Sheepdog. 
Although statistical significance could not be confirmed 
for every breed, both types of changes were found in Bel-
gian Tervuren, Collie and Golden Retriever, sometimes 
in the same patient. Nonetheless, metaplasia and dys-
plasia can present as discrete, flat changes that are easily 
overlooked and possibly underdiagnosed [24], especially 
when considering the limitations of current white light 
endoscopy modalities available and non-directed sam-
pling procedures in veterinary medicine. Visual enhance-
ment techniques such as chromoendoscopy and narrow 
band imaging (Fig.  7) may help improve the diagnostic 
yield of discrete mucosal changes [9].
One of the major challenges in veterinary gastroenter-
ology is that the extension and severity of macroscopic 
changes seen during endoscopy are not always consistent 
with the respective histopathological findings from endo-
scopic biopsy [25]. Cognitive aspects including specific 
knowledge, endoscopist experience and training, stand-
ardized grading systems, image quality and meticulous 
examination techniques are fundamental for the detec-
tion of subtle lesions [26]. In this study, the biopsies and 
histologic sections were prepared and then examined 
according to a uniform in-house standard. Such proto-
cols help to control the risk of inaccuracy related to lack 
Fig. 4 Endoscopic and corresponding histologic images of an 
8-year-old female Belgian Tervuren showing gastric adenocarcinoma. 
a White light endoscopic image of a gastric adenocarcinoma. 
Histology: b Well differentiated gastric adenocarcinoma with invasion 
of the muscularis mucosae (arrow). HE stain, Obj. 20×
Fig. 5 Endoscopic and corresponding histologic images of a 10-year 
old female Belgian Tervuren representing gastric adenocarcinoma. 
a White light endoscopic image of a diffuse mass in the stomach. 
Histology: b Invasive gastric adenocarcinoma, with atypical tubular 
structures (arrow) and single cell invasion of deeper layers of the 
gastric wall (arrow), and c classical signet ring cells (arrow). b IHC 
cytokeratin stain, Obj. 20×. c HE stain, Obj. 40×
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of uniformity on sample quality and to interobserver var-
iation in histopathological evaluation. Such issues have 
been reported as potentially detrimental when histo-
logic material or reports originated from several different 
institutions are utilized [27, 28].
The diagnosis of metaplastic or dysplastic changes 
in breeds with predispositions to GC might indicate a 
stepwise progression in dogs, comparable to the better 
known pathway towards GC in humans [10]. Studies in 
Lundehund dogs with GC ponder on a similar patho-
genesis [17, 18]. This might be the case especially for 
the Belgian Tervuren with its significantly higher rela-
tive risk for the suspected pre-neoplastic changes, along 
with its marked predisposition for GC. This hypothesis 
might be further explored by staging suspected lesions 
and screening dogs selected from predisposed breeds. 
Research should aim at applying more advanced endo-
scopic approaches such as chromoendoscopy or narrow 
band imaging, which are proven modalities in humans 
for improving the targeted sampling of lesions [29] 
that might be easily overlooked when using white light 
endoscopy alone. Metaplasia and dysplasia have not 
been consistently studied in canine gastroenterology 
and their potentially relevant role in the pathogenesis 
Fig. 6 Endoscopic and corresponding histologic images of a 
9-year-old castrated male Dachshund representing metaplasia. 
a White light endoscopic image of gastric fundus with discrete 
mucosal changes. Histology: b Mucous/intestinal metaplasia within 
the gastric fundus; elongated hyperplastic mucous neck regions of 
fundic glands and diffuse moderate lymphoplasmacytic gastritis. 
c Increased mitotic figures within the hyperplastic mucous cells of 
the glandular neck area (arrow). Scattered parietal cells are visible 
(arrowhead) within the basal area of the glands. HE stain, b Obj. 20×, 
c Obj. 40×
Fig. 7 Endoscopic and corresponding histologic images of a 
9-year-old female Belgian Tervuren showing dysplasia. Endoscopic 
images (a, b, c) show diffuse mucosal texture irregularity along gastric 
fundus and body: a chromoendoscopy (CE), b narrow band imaging 
(NBI), c CE and NBI combined. Histology: d dysplasia of the fundic 
glands, with glandular dilatation and distortion. e Cellular dysplasia 
with flattening of the glandular cells and loss of cellular polarity 
(arrows). HE stain, d Obj. 20×, e Obj. 40×
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of canine GC must be further investigated, whereas 
in humans well-established staging protocols and 
advanced therapeutic approaches are routinely applied 
[30]. While standard guidelines for histopathology 
evaluation remain fluid in veterinary medicine, novel 
immune staining techniques and genetic examination 
of biopsy samples may provide valuable opportunities 
for both research and diagnosis in the near future [31].
The retrospective nature of the study and the sole inclu-
sion of dogs that had undergone GDS led to some limita-
tions that possibly influenced the interpretation of our 
results. This study did not include GC diagnosed after 
necropsy or full-thickness biopsy but rather focused on 
the findings of endoscopic biopsy samples. This approach 
resulted in a small case load, as endoscopy is typically 
performed in a relatively small proportion of dogs in the 
clinical population, thus it relies on specific indications 
and also the owner’s compliance. A possible bias of indi-
cation for endoscopic procedures by different clinicians 
(e.g. awareness of certain breed predispositions), over 
such an extended time period, cannot be ruled out.
It is also worth mentioning that even in this selected 
population of canine patients with clinical signs of gas-
trointestinal disease, GCs were seen only in few individu-
als (8/180 = 4.4%), which further corroborates the rarity 
of the condition. The frequency of disease in this study 
cannot be directly compared with previous studies that 
used different approaches. However, the low frequency 
of diagnosis and the advanced age at diagnosis of GC in 
dogs found in this setting are in agreement with previous 
reports [1–4, 14].
Gaining knowledge about the actual prevalence of 
metaplasia and dysplasia in dogs may help to determine 
their possible role as pre-neoplastic changes. Further-
more, patient follow-up after the diagnosis of metaplastic 
and dysplastic changes might contribute to the knowl-
edge about canine gastric carcinogenesis. Multi-center, 
prospective studies that utilize standardized approaches 
could help overcome the limitations related to reduced 
sample sizes in veterinary research, especially with regard 
to uncommon disease conditions like the ones reported 
in this study.
Conclusions
Belgian Tervurens, Collies, Siberian Huskies, Cairn Ter-
riers and Australian Terriers underwent GDS more often 
than dogs of other breeds in our study population. The 
Belgian Tervurens were found to be at much higher 
risk (19-fold) of being diagnosed with GC than dogs of 
other breeds, which further corroborates predisposition 
for GC in this breed. Metaplastic or dysplastic changes 
were slightly more frequent than GC. Although no causal 
relationship could be established thus far, the presence of 
lesions of all three types in breeds such as the Collie, the 
Golden Retriever, and chiefly the Belgian Tervuren, even 
in the face of these low case numbers, might be a sign of 
associated pathogenesis requiring further investigation.
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